Sunday, November 30, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Method By Which A Protein That Determines Cell Polarity Prevents Breast Cancer
http://www.medicalnewstoday.com/articles/131118.php
In breast tissue, cells lining the breast's ducts have a certain shape that is required to maintain both organ structure and function. All breast cancers display a loss of this characteristic organization, but very little is known about the molecules and pathways that regulate tissue structure and the role they play during cancer.

----------------------------------------------
** CANCER / ONCOLOGY News **

Bevacizumab Associated With Increased Venous Thromboembolism
http://www.medicalnewstoday.com/articles/131247.php
Bevacizumab, a cancer drug, may be associated with an increased risk of venous thromboembolism, according to an analysis of several randomized controlled trials released on November 19, 2008 in <i>JAMA</i>.

Robotic Partial Nephrectomy For Renal Hilar Tumors: A Multi-Institutional Analysis
http://www.medicalnewstoday.com/articles/131244.php
UroToday.com - Our multi-institutional study on robotic partial nephrectomy for renal hilar tumors is the first to focus solely on renal hilar tumors and represents one of the largest series in the world.

Drop In Colorectal Cancer Deaths
http://www.medicalnewstoday.com/articles/131103.php
The American Society for Gastrointestinal Endoscopy (ASGE) heralds the recent news of a decline in U.S. cancer deaths and incidence rates, with colorectal cancer among the top three cancers with significant declines.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Drop In Colorectal Cancer Deaths
http://www.medicalnewstoday.com/articles/131103.php
The American Society for Gastrointestinal Endoscopy (ASGE) heralds the recent news of a decline in U.S. cancer deaths and incidence rates, with colorectal cancer among the top three cancers with significant declines.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Age And Grade Trends In Prostate Cancer (1974-2003): A Surveillance, Epidemiology, And End Results Registry Analysis
http://www.medicalnewstoday.com/articles/131204.php
UroToday.com - In this study we report an analysis of prostate cancer grade migration trends, by age, using <b>S</b>urveillance, <b>E</b>pidemiology, and <b>E</b>nd <b>R</b>esults (SEER) data over a 30-year period from 1974 to 2003.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Saturday, November 29, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Insight Into Adaptive Ability Of Cells Offered By Rong Li Lab
http://www.medicalnewstoday.com/articles/131071.php
The Stowers Institute's Rong Li Lab has published findings that shed light on the ability of cells to adapt to disruptions to their basic division machineries - findings that may help explain how cancer cells elude the body's natural defense mechanisms or chemotherapy treatment.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

Women Smokers' Longevity Cut By 14.5 Years Because Of Smoking
http://www.medicalnewstoday.com/articles/131229.php
One in every five adult women in the United States still smokes, even though smoking takes an average of 14.5 years off their lives, says the American College of Obstetricians and Gynecologists (ACOG).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Diffusion And Perfusion MR Imaging Of The Prostate
http://www.medicalnewstoday.com/articles/131219.php
UroToday.com - The current gold standard for diagnosis of prostate cancer is the Transrectal Ultrasound (TRUS) guided prostate biopsy, initiated by elevated PSA-levels or a Digital Rectal Examination (DRE) suspicious for prostate cancer.

Comparing Biochemical Relapse-Free Survival Between Primary Gleason Score 3 & Primary Gleason Score 4 For Biopsy Gleason Score 7 Prostate Cancer
http://www.medicalnewstoday.com/articles/131217.php
UroToday.com - We feel that this work is an important contribution to the literature as it compares outcomes across three different modalities. One aspect with which the authors struggled was how to address the poor outcomes for surgical patients.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Friday, November 28, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

New Phase III Study Of Avastin In Advanced Breast Cancer Meets Its Primary Endpoint Of Increasing The Time Patients Live
http://www.medicalnewstoday.com/articles/131155.php
Third study confirming the benefit of Avastin in breast cancer shows that Avastin can be effectively combined with commonly used chemotherapiesRoche announced that the Avastin study RIBBON-1 met its primary endpoint of increasing the time women with breast cancer lived without their disease advancing (known as progression-free survival) compared to chemotherapy alone, as determined by the treating physicians.

IU Simon Cancer Center Researchers' Breast Cancer Trials Offer Recognized Potential To Improve Treatment, Survival
http://www.medicalnewstoday.com/articles/131074.php
Two breast cancer clinical trials led by Indiana University Melvin and Bren Simon Cancer Center researchers are among 13 selected by a national panel as having the greatest potential to improve treatment and survival.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Drug For Skin Cancer Approaching Commercialization
http://www.medicalnewstoday.com/articles/131152.php
A drug that is activated by light can be a quick, simple, and cheap treatment for tens of thousands of patients with skin cancer in Sweden alone. Researcher Leif Eriksson's team at rebro University in Sweden has now received about SEK 4 million from government research financiers, the Swedish Research Council and Vinnova, to further develop and commercialize the method.

Phase 3 Study Of Subcutaneous Relistor For Opioid-Induced Constipation For Chronic Non-Cancer Pain
http://www.medicalnewstoday.com/articles/131139.php
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that a phase 3 clinical study investigating RELISTOR&reg; (methylnaltrexone bromide) subcutaneous injection to treat opioid-induced constipation (OIC) in patients with chronic, non-cancer pain achieved statistical significance for the primary and key secondary efficacy endpoints.

NICE Approves Lung-Cancer Drug Provided Manufacturer Roche Offers Discounted Price For NHS, UK
http://www.medicalnewstoday.com/articles/131131.php
The National Institute for Health and Clinical Excellence (NICE) has recommended erlotinib, an epidermal growth factor receptor inhibitor, as an alternative to docetaxel as a second-line treatment option for patients with non-small-cell lung cancer (NSCLC) provided the manufacturer (Roche) supplies erlotinib at a discounted and equivalent price to docetaxel.

IU Simon Cancer Center Researchers' Breast Cancer Trials Offer Recognized Potential To Improve Treatment, Survival
http://www.medicalnewstoday.com/articles/131074.php
Two breast cancer clinical trials led by Indiana University Melvin and Bren Simon Cancer Center researchers are among 13 selected by a national panel as having the greatest potential to improve treatment and survival.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

NICE Approves Lung-Cancer Drug Provided Manufacturer Roche Offers Discounted Price For NHS, UK
http://www.medicalnewstoday.com/articles/131131.php
The National Institute for Health and Clinical Excellence (NICE) has recommended erlotinib, an epidermal growth factor receptor inhibitor, as an alternative to docetaxel as a second-line treatment option for patients with non-small-cell lung cancer (NSCLC) provided the manufacturer (Roche) supplies erlotinib at a discounted and equivalent price to docetaxel.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

St. Jude Identifies Genomic Causes Of A Certain Type Of Leukemia Relapse
http://www.medicalnewstoday.com/articles/131144.php
Scientists at St. Jude Children's Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse. The finding offers a pathway to designing treatments for ALL relapse in children and, ultimately, in adults.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Thursday, November 27, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Siemens Introduces New Standard Of Care For Breast Ultrasound
http://www.medicalnewstoday.com/articles/130982.php
Siemens Healthcare (<a href="http://www.siemens.com/healthcare" target="_blank" rel="nofollow">http://www.siemens.com/healthcare</a>) highlights the ACUSON S2000(TM) Automated Breast Volume Scanner (ABVS)(1),the world's first multi-use, automated volume breast ultrasound system, at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 30 to December 5 at McCormick Place (Booth #922, East Building/Lakeside Center, Hall D) in Chicago.

----------------------------------------------
** CANCER / ONCOLOGY News **

Statement On Publication Of National Audit Office Report: 'End Of Life Care' - Help The Hospices, UK
http://www.medicalnewstoday.com/articles/131049.php
Help the Hospices, the leading charity supporting hospice care throughout the UK, welcomes yeasterday's (Wednesday 26 November) publication of the first ever National Audit Office report on care at the end of life, the most in-depth study of its kind to look at this issue.

Enrollment In Provectus' Phase 2 Melanoma Clinical Trial Reaches Halfway Point
http://www.medicalnewstoday.com/articles/131029.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that the first fifty percent (40 of 80) of melanoma subjects have been treated in its Phase 2 clinical trial of PV-10.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
http://www.medicalnewstoday.com/articles/130984.php
Simbionix USA Corp, an international company using leading edge simulation to advance clinical performance, announces the world-wide release of a breakthrough training simulation of the laparoscopic colorectal procedure.

----------------------------------------------
** LUNG CANCER News **

NICE Issues Guidance On The Use Of Erlotinib For The Treatment Of Non-Small-Cell Lung Cancer
http://www.medicalnewstoday.com/articles/130957.php
The National Institute for Health and Clinical Excellence (NICE) has today (26 November) published final guidance on the use of erlotinib for the treatment of non-small-cell lung cancer (NSCLC).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

2008 Prostate Cancer Retreat Available Online - Prostate Cancer Foundation
http://www.medicalnewstoday.com/articles/130969.php
The Prostate Cancer Foundation (PCF) has made presentations from its 2008 Scientific Retreat available online. The PCF's annual retreat provides a forum to review advances in prostate cancer research aimed at reducing death and suffering from this prevalent men's disease.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Wednesday, November 26, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Racial Disparities In Breast Cancer Care May Be Reduced By The Implementation Of A Tracking And Feedback Registry
http://www.medicalnewstoday.com/articles/130892.php
Alerting surgeons when their breast cancer patients did not attend a follow-up consultation with a medical oncologist was associated with a reduction in racial disparities in adjuvant therapy, according to a non-randomized study published in the November 25 online issue of the <i>Journal of the National Cancer Institute</i>.

Study Finds Some Invasive Breast Cancer Tumors Might Regress Without Treatment
http://www.medicalnewstoday.com/articles/130851.php
<BR >A new <A href="http://archinte.ama-assn.org/cgi/content/full/168/21/2311" target=_new>study</A> of breast cancer in Norwegian women suggests that some breast tumors may regress on their own over time, the <A href="http://www.

Mammogram Most Effective 12 Months After Radiation Treatment
http://www.medicalnewstoday.com/articles/130819.php
Breast cancer patients who receive breast-conserving therapy and radiation do not need a follow-up mammogram until 12 months after radiation, despite current American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) guidelines that recommend follow-up mammograms at between six and 12 months after radiation, according to a November 15 study in the <I>International Journal of Radiation Oncology Biology Physics</I>, the official journal of the American Society for Therapeutic Radiology and Oncology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Healthy Bonding Between Cells Provoked By Tiny Protein
http://www.medicalnewstoday.com/articles/130933.php
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell "friendships" operate in much the same way and that dysfunctional bonding is linked to the spread of cancer.

News From The Journal Of The National Cancer Institute, Nov. 25
http://www.medicalnewstoday.com/articles/130897.php
<b>No Association Between Fat, Protein, and Meat Consumption and Kidney Cancer</b>There is no association between consumption of fat, protein, or meat and kidney cancer, according to a pooled analysis of prospective studies.

Survival In Early Stage Endometrial Cancer Not Improved By Pelvic Lymphadenectomy
http://www.medicalnewstoday.com/articles/130886.php
Systematic use of pelvic lymphadenectomy (removal of the lymph nodes) does not improve disease-free or overall survival in women with early-stage endometrial cancer, according to a randomized trial published online November 25 in the <i>Journal of the National Cancer Institute</i>.

'Bodyguard' Turned Into Killer In Cancer Cells
http://www.medicalnewstoday.com/articles/130880.php
If you're a cancer cell, you want a protein called Bcl-2 on your side because it decides if you live or die. It's usually a trusted bodyguard, protecting cancer cells from programmed death and allowing them to grow and form tumors.

Lung Cancer - NICE Recommends Oral Tarceva(R) (erlotinib) As An Alternative To Intravenous Chemotherapy, UK
http://www.medicalnewstoday.com/articles/130873.php
Today the National Institute for Health and Clinical Excellence (NICE) recommends Tarceva (erlotinib) as a clinically and cost-effective alternative to IV chemotherapy (i.e. docetaxel) for the 2nd line treatment of non-small cell lung cancer.

Monash University Scientists Have Identified A Protein That Stops The Growth Of Cervical Cancer
http://www.medicalnewstoday.com/articles/130844.php
Animal studies led by Associate Professor Jun-Ping Liu, from the Department of Immunology, have shown that the protein bone morphogenetic protein-7 (BMP-7), when applied to cervical tumours in mice, can halve the size of the tumours in less than a week.

Patent For Improved Cancer Therapy Device Received: New Design Would Deliver More Precise Radiation Doses At Lower Cost
http://www.medicalnewstoday.com/articles/130833.php
Four physicists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a "medical synchrotron" capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue.

Ovarian Cancer Research Targets Chemo-resistance
http://www.medicalnewstoday.com/articles/130831.php
A QUT research project looking at ways to block chemo-resistant enzymes which also cause tumours to grow and spread, has been rewarded with a grant of $783,750 from the National Health and Medical Research Council.

Rates Of New Cases And Deaths From Cancer Down In The US
http://www.medicalnewstoday.com/articles/130824.php
The latest annual report by leading cancer organizations in the US found that overall rates of new cancer cases and deaths have fallen for the first time since the report was first compiled ten years ago, but within those figures there are disturbingly large state and regional differences in lung cancer rates among women, highlighting the need to tighten tobacco control in many states.

Radiation Before Surgery Improves Pancreatic Cancer Outcomes
http://www.medicalnewstoday.com/articles/130809.php
Pancreatic cancer is one of the deadliest and most difficult to treat cancers. Now, in a major step forward, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have shown that administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumors.

Light Sciences Oncology Completes Patient Enrollment In Phase 3 Clinical Trial Of Litx As A Treatment For Hepatocellular Carcinoma
http://www.medicalnewstoday.com/articles/130807.php
Light Sciences Oncology, Inc. (LSO) announced the completion of enrollment in a global Phase 3 clinical trial of Light Infusion Therapy(TM) (Litx(TM)) as a treatment for unresectable hepatocellular carcinoma (HCC), also known as hepatoma or primary liver cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Blogs Examine Obama Appointees, Ovarian Cancer Test, European Abortion Laws
http://www.medicalnewstoday.com/articles/130856.php
<BR >The following is a summary of selected women's health-related blog entries.<BR /><BR />~ "<A href="http://www.rhrealitycheck.org/blog/2008/11/24/ladies-first-newest-obama-appointments" target=_new>Progressive and Pro-Choice: Obama's Latest Team Members</A>," <STRONG>Amie Newman,</STRONG> <STRONG>RH Reality Check</STRONG>: Newman reports that two of President-elect Barack Obama's latest appointments to his incoming administration "offer much hope to advocates of women's rights.

Monash University Scientists Have Identified A Protein That Stops The Growth Of Cervical Cancer
http://www.medicalnewstoday.com/articles/130844.php
Animal studies led by Associate Professor Jun-Ping Liu, from the Department of Immunology, have shown that the protein bone morphogenetic protein-7 (BMP-7), when applied to cervical tumours in mice, can halve the size of the tumours in less than a week.

----------------------------------------------
** COLORECTAL CANCER News **

News From The Journal Of The National Cancer Institute, Nov. 25
http://www.medicalnewstoday.com/articles/130897.php
<b>No Association Between Fat, Protein, and Meat Consumption and Kidney Cancer</b>There is no association between consumption of fat, protein, or meat and kidney cancer, according to a pooled analysis of prospective studies.

----------------------------------------------
** LUNG CANCER News **

Annual Report To The Nation On Cancer Co-Authored By LSUHSC's Dr. Xiao Cheng Wu
http://www.medicalnewstoday.com/articles/130953.php
Xiao Cheng Wu, MD. MPH, Associate Professor and Assistant Director of the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans School of Public Health, co-authored the Annual Report to the Nation on the Status on Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control.

Lung Cancer - NICE Recommends Oral Tarceva(R) (erlotinib) As An Alternative To Intravenous Chemotherapy, UK
http://www.medicalnewstoday.com/articles/130873.php
Today the National Institute for Health and Clinical Excellence (NICE) recommends Tarceva (erlotinib) as a clinically and cost-effective alternative to IV chemotherapy (i.e. docetaxel) for the 2nd line treatment of non-small cell lung cancer.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Researchers Identify Novel Approach For Suppressing Prostate Cancer Development
http://www.medicalnewstoday.com/articles/130820.php
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Tuesday, November 25, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Somo-InSIGHT Study, Breast Cancer Screening Study Beginning Early 2009 Enrolling Over 20,000 Women
http://www.medicalnewstoday.com/articles/130760.php
U-Systems, the innovative leader in dedicated breast ultrasound systems, today announced its plans to conduct a multi-center breast cancer screening study named <i>somo•InSIGHT</i>, with more than 20,000 women, using its proprietary Automated Breast Ultrasound System (ABUS).

Breakthrough Breast Cancer Comment Re Research Suggesting Breast Screening May Detect Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130669.php
Dr Alexis Willett from Breakthrough Breast Cancer says: "This research puts forward an interesting theory about breast cancer development. However, it is not currently possible to predict whether early changes picked up by breast screening will progress so treatment is usually offered to prevent breast cancer developing.

Mammograms May Identify Cancers That Would Otherwise Just Regress
http://www.medicalnewstoday.com/articles/130644.php
Researchers in Norway found there was a 22 per cent higher rate of detected breast cancer among women who had mammograms every two years compared to women screened every six years raising the possibility that some breast cancers just regress naturally without treatment.

Ipsogen Launches A New Test To Determine Tumor HER2 Status And Guide Herceptin(R) Prescription In Breast Cancer
http://www.medicalnewstoday.com/articles/130627.php
IPSOGEN SA (Marseille, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukemia and breast cancer announced the European launch of MapQuant Dx(TM) HER2 test.

Mammograms May Detect Some Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130603.php
Breast cancer rates increased significantly in four Norwegian counties after women there began undergoing mammography every two years, according to a report in the November 24 issue of <i>Archives of Internal Medicine,</i> one of the <i>JAMA/Archives</i> journals.

----------------------------------------------
** CANCER / ONCOLOGY News **

Exelixis And Bristol-Myers Squibb To Co-Develop XL413, A Selective Cdc7 Inhibitor
http://www.medicalnewstoday.com/articles/130798.php
Exelixis, Inc. (Nasdaq:EXEL) today announced that Bristol-Myers Squibb Company (NYSE:BMY) has exercised its option to develop and commercialize Exelixis' investigational new drug (IND) candidate XL413, a selective inhibitor of Cdc7.

Varian Medical Systems Introducing OncoView&trade; - An Oncology Specific Image Management And Storage Solution
http://www.medicalnewstoday.com/articles/130790.php
Varian Medical Systems (NYSE: VAR) today is introducing a new product that makes it easier for clinicians to store, manage and view images generated during cancer treatments. Varian will showcase its new OncoView&trade; image management and storage solution at the Radiological Society of North America (RSNA) meeting in Chicago, November 30 - December 4, 2008.

National Comprehensive Cancer Network Receives $1.5 Million Grant To Research Targeted Therapy In Bladder Cancer
http://www.medicalnewstoday.com/articles/130780.php
NCCN (The National Comprehensive Cancer Network) has been awarded a $1.5 Million grant from Bristol-Myers Squibb Company and ImClone Systems Incorporated to fund research on the antibody cetuximab in patients with bladder cancer.

BloodCenter Of Wisconsin Launches New Test To Diagnose Resistance To Common Cancer Therapy
http://www.medicalnewstoday.com/articles/130773.php
BloodCenter of Wisconsin today announced the availability of BCR-ABL Kinase Domain Mutation Analysis, a new DNA sequencing assay designed to help oncologists develop appropriate therapeutic strategies tailored to the specific needs of patients with chronic myeloid (or myelogenous) leukemia (CML).

Clot Risk Increased By Transfusions In Hospitalized Cancer Patients
http://www.medicalnewstoday.com/articles/130755.php
Blood transfusions used to treat anemia in patients with cancer are associated with an increased risk of life-threatening blood clots, at a similar rate as other treatments for cancer-induced anemia, according to scientists at the University of Rochester Medical Center.

Novel Device May Enhance Chemotherapy Treatment In Brain Tumors
http://www.medicalnewstoday.com/articles/130743.php
NovoCure Ltd. presented results evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.

Commercialisation Of Yondelis(R) For The Treatment Of Soft Tissue Sarcoma Approved In Russia
http://www.medicalnewstoday.com/articles/130720.php
The Russian regulatory body has approved YONDELIS&reg; (trabectedin) for the treatment of soft tissue sarcoma in adults. This represents another approval for YONDELIS&reg; for treatment soft tissue sarcoma (STS) following upon its approval in Europe in September 2007, which opens up new opportunities in markets with enormous growth potential.

Breakthrough Breast Cancer Comment Re Research Suggesting Breast Screening May Detect Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130669.php
Dr Alexis Willett from Breakthrough Breast Cancer says: "This research puts forward an interesting theory about breast cancer development. However, it is not currently possible to predict whether early changes picked up by breast screening will progress so treatment is usually offered to prevent breast cancer developing.

Mammograms May Identify Cancers That Would Otherwise Just Regress
http://www.medicalnewstoday.com/articles/130644.php
Researchers in Norway found there was a 22 per cent higher rate of detected breast cancer among women who had mammograms every two years compared to women screened every six years raising the possibility that some breast cancers just regress naturally without treatment.

December Is Cancer-Related Fatigue Awareness Month
http://www.medicalnewstoday.com/articles/130638.php
Between 70 and 100 percent of cancer patients receiving treatment have fatigue, according to the American Cancer Society. Up to one-half of all survivors have reported fatigue lasting months or even years after treatment.

New Cancer Treatment Shrinks Pancreatic Tumor
http://www.medicalnewstoday.com/articles/130628.php
A new cancer treatment is realizing outstanding results against pancreatic cancer. Following five weeks of treatment, a patient's large, stage 4 tumor was reduced in size by 70%. After seven more weeks of treatment, it no longer could be definitely identified on scans.

Medarex Announces Initiation Of Phase 1b Clinical Development Program With MDX-1106 For The Treatment Of Cancer
http://www.medicalnewstoday.com/articles/130625.php
Medarex, Inc. (Nasdaq: MEDX) announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer.

ASGE And The Pancreatic Cancer Action Network Partner To Raise Awareness About Pancreatic Cancer
http://www.medicalnewstoday.com/articles/130621.php
The American Society for Gastrointestinal Endoscopy (ASGE) and the Pancreatic Cancer Action Network are teaming up this November to raise awareness about pancreatic cancer, educating patients about the disease and the resources that are available for them.

UM Study Finds Late Diagnosis And Under-Treatment To Blame For Disparities In Cervical Cancer Survival
http://www.medicalnewstoday.com/articles/130618.php
Disparities in cervical cancer survival can be traced to differences in access to care for certain racial, ethnic and socioeconomic groups, according to a University of Miami Miller School of Medicine study of more than 5,300 Florida women.

The Improvement Foundation's Groundbreaking Cancer Programme - Improving Public Awareness And Fast Referral Of Cancer, UK
http://www.medicalnewstoday.com/articles/130617.php
Under a 'National Awareness and Early Diagnosis Initiative' (NAEDI), launched by the Department of Health last week, work is already underway in the UK to improve public awareness and fast referral of cancer, with pilot schemes in 20 Primary Care Trusts (PCTs) run by the Improvement Foundation.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

UM Study Finds Late Diagnosis And Under-Treatment To Blame For Disparities In Cervical Cancer Survival
http://www.medicalnewstoday.com/articles/130618.php
Disparities in cervical cancer survival can be traced to differences in access to care for certain racial, ethnic and socioeconomic groups, according to a University of Miami Miller School of Medicine study of more than 5,300 Florida women.

----------------------------------------------
** COLORECTAL CANCER News **

Genomic Signature Of Colon Cancer May Individualize Treatment
http://www.medicalnewstoday.com/articles/130730.php
Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens.

----------------------------------------------
** LUNG CANCER News **

European Cancer Specialists Mandate For Change - Better Emotional Support And Resouces For Lung Cancer Patients
http://www.medicalnewstoday.com/articles/130652.php
A coalition of European cancer specialists today called for major changes in the provision of emotional support for lung cancer patients. In conjunction with the International Psycho-Oncology Society, they issued a <i>Mandate for Change,</i> highlighting basic rights for patients in terms of their emotional wellbeing and quality of life.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

U.S. Approval For Clolar(R) To Treat Adult Acute Myeloid Leukemia Sought By Genzyme
http://www.medicalnewstoday.com/articles/130777.php
Genzyme Corporation (Nasdaq: GENZ) announced today that it has filed a supplemental New Drug Application with the U.S. Food and Drug Administration for the use of Clolar&reg; (clofarabine) to treat adult patients with acute myeloid leukemia (AML).

FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Diffuse Large B-Cell Lymphoma
http://www.medicalnewstoday.com/articles/130765.php
Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.

Potential New Drug Target For Chronic Leukemia Identified By UCSD Researchers
http://www.medicalnewstoday.com/articles/130721.php
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

USC Researchers Identify Novel Approach For Suppressing Prostate Cancer Development
http://www.medicalnewstoday.com/articles/130656.php
Inactivation of a specific protein associated with cancer development halts prostate tumor progression in animal model Los Angeles, Calif. Nov. 24, 2008 California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Monday, November 24, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/130595.php
Genentech, Inc. (NYSE:DNA) today announced that a Phase III study (RIBBON 1) of Avastin&reg; (bevacizumab), in combination with taxane, anthracycline-based or capecitabine chemotherapies for first-line treatment of metastatic HER2-negative breast cancer, met its primary endpoint of increasing the time patients lived without their disease advancing, compared to the chemotherapies alone.

First Lady Laura Bush's Partnership For Breast Cancer Awareness And Research Extends To Panama
http://www.medicalnewstoday.com/articles/130451.php
The University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian Fernández de Torrijos, the First Lady of Panama.

----------------------------------------------
** CANCER / ONCOLOGY News **

Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/130595.php
Genentech, Inc. (NYSE:DNA) today announced that a Phase III study (RIBBON 1) of Avastin&reg; (bevacizumab), in combination with taxane, anthracycline-based or capecitabine chemotherapies for first-line treatment of metastatic HER2-negative breast cancer, met its primary endpoint of increasing the time patients lived without their disease advancing, compared to the chemotherapies alone.

Transfusion Of Fresh Blood Could Play A Role In Surgical Outcomes Of Cancer Patients
http://www.medicalnewstoday.com/articles/130573.php
Among other findings, a study presented in the December issue of <i>Anesthesiology </i>suggests that the use of fresh red blood cells in transfusions for cancer patients could improve cancer recurrence and long-term survival rates.

Burzynski Research Institute, Inc. Presents Promising Phase II Data On Malignant Glioma
http://www.medicalnewstoday.com/articles/130546.php
Today at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology, BRI announced encouraging results from the ongoing Phase II clinical trials of two of its investigational drugs, Atengenal (A10) and Astugenal (AS2-1), defined as antineoplastons therapy (ANP).

Bad Breath Linked To Bacteria That Cause Stomach Ulcer And Cancer
http://www.medicalnewstoday.com/articles/130539.php
New research from Japan found bacteria that cause stomach ulcers and cancer living in the mouths of some people with bad breath, even though they did not show signs of stomach illnesses.The study was the work of Dr Nao Suzuki from Fukuoka Dental College in Fukuoka, Japan and colleagues and is published in the December issue of the <i>Journal of Medical Microbiology</i>.

Med School Discovery Could Lead To Better Cancer Diagnosis, Drugs
http://www.medicalnewstoday.com/articles/130457.php
A Florida State University College of Medicine research team led by Yanchang Wang has discovered an important new layer of regulation in the cell division cycle, which could lead to a greater understanding of the way cancer begins.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Most Wirral Parents Say Yes To Cervical Cancer Vaccination For Daughters, England
http://www.medicalnewstoday.com/articles/130566.php
The majority of the Wirral parents asked if they would consent to their daughters being immunised against cervical cancer in the first wave of vaccinations have already agreed. The majority of the Wirral parents asked if they would consent to their daughters being immunised against cervical cancer in the first wave of vaccinations have already agreed.

----------------------------------------------
** COLORECTAL CANCER News **

Colorectal Cancer Screening Detects Unrecognised Disease
http://www.medicalnewstoday.com/articles/130481.php
Screening for colorectal cancer detects four out of ten cancers and should be carefully designed to be more effective, according to a study published today on <i>bmj.com</i>. About one in 20 people in the UK develop bowel cancer during their lifetime.

----------------------------------------------
** LUNG CANCER News **

Lung Cancer Needs Awareness Too
http://www.medicalnewstoday.com/articles/130575.php
Lung cancer kills more than four times as many Americans as breast cancer. But while pink ribbons trumpet Breast Cancer Awareness Month throughout October, little attention is paid to lung cancer in November, which is that disease's awareness month.

Mesothelioma Victims Center Offers The Best Free Help & Advice Service For A Victim Of Mesothelioma
http://www.medicalnewstoday.com/articles/130557.php
The Mesothelioma Victims Center is a world class free service designed to assist all victims of Mesothelioma, or to assist the families of victims, who have this disease. The group has just expanded its service to assist Mesothelioma victims or their families to find the right law firm to help them.

Progression Of Precancerous Lung Lesions Analyzed
http://www.medicalnewstoday.com/articles/130551.php
The risk of precancerous lesions developing into <a href="http://www.roswellpark.org/Patient_Care/Types_of_Cancer/Lung_Cancer" target="_blank" rel="nofollow">lung cancer </a> is highest among current and heavy smokers, according to a study presented by Vijay Jayaprakash, MBBS, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute (RPCI), at the American Association for Cancer Research (AACR) Seventh International Frontiers in Cancer Prevention Research, November 16 -19, Washington, DC.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Prediagnostic BMI, Plasma C-Peptide Concentration, And Prostate Cancer-Specific Mortality In Men With Prostate Cancer: A Long-Term Survival Analysis
http://www.medicalnewstoday.com/articles/130468.php
UroToday.com - A significant level of interest has developed in the association of prostate cancer (CaP) specific mortality (PCSM) with nutrition, lifestyle variables, and treatment effects. The data surrounding a man's body mass index (BMI) and PCSM is mixed, but likely suggest an association between high BMI and an increased risk of dying from CaP.

Nerves At The Ventral Prostatic Capsule Contribute To Erectile Function: Initial Electrophysiological Assessment In Humans
http://www.medicalnewstoday.com/articles/130466.php
UroToday.com - When performing nerve sparing radical prostatectomy, how high up on the lateral prostatic fascia do urologists need to go to release the neurovascular bundle (NVB)? Are there even functional nerve fibers higher than the main bundle located at the 5 o'clock position? This question is answered by Dr.

Inverse Association Between Histologic Inflammation In Needle Biopsy Specimens And Prostate Cancer In Men With Serum PSA Of 10-50 Ng/ML
http://www.medicalnewstoday.com/articles/130465.php
UroToday.com - In the online edition of <i>Urology</i>, Dr. Tomoaki Terakawa and associates reported on parameters that may help determine whether a man with a PSA between 10 and 50ng/ml with a negative prostate biopsy is likely to have prostate cancer (CaP) later on.

EMR At 1.5 Tesla To Assess Local Recurrence After Radical Prostatectomy Using T2-Weighted & Contrast-Enhanced Imaging
http://www.medicalnewstoday.com/articles/130464.php
UroToday.com - Imaging accuracy for local recurrence of prostate cancer (CaP) and the use of endorectal magnetic resonance (eMR) has not been significantly assessed. In the online version of European Radiology, Dr.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Sunday, November 23, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Metastatic Renal Cell Carcinoma: Results Of A Population-Based Study With 25 Years Follow-Up
http://www.medicalnewstoday.com/articles/130423.php
UroToday.com - The Munich Cancer Registry (MCR) was established in 1978 as the clinical registry of the Munich Cancer Centre and in the beginning cooperated with the two University hospitals in Munich.

1st Nonphysician Elected National President Of American Cancer Society
http://www.medicalnewstoday.com/articles/130300.php
Elizabeth T. H. (Terry) Fontham, MPH, DrPH, Dean of the LSU Health Sciences Center New Orleans School of Public Health, became the first non-physician elected national President of the American Cancer Society when she was inducted at a special ceremony during the Society's National Assembly Meeting on November 20, 2008 in New York City.

Journal Of Clinical Investigation Table Of Contents: Nov. 20, 2008
http://www.medicalnewstoday.com/articles/130277.php
<b>Preventing tumor cells from refueling: a new anticancer approach?</b>New data, generated in mice, by Pierre Sonveaux and colleagues, at Université catholique de Louvain, Belgium, have identified a potential new target for anticancer therapeutics.

Delaying The Evolution Of Drug Resistance
http://www.medicalnewstoday.com/articles/130272.php
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Promising Clinical Data On Gen-Probe's APTIMA(R) HPV Test Presented At Major European Medical Meeting
http://www.medicalnewstoday.com/articles/130391.php
Gen-Probe's (Nasdaq: GPRO) CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV) infections that are associated with cervical cancer or precancerous lesions, according to nine oral presentations and two scientific posters presented last week by independent and Gen-Probe researchers at the international conference of the European Research Organization on Genital Infection and Neoplasia (EUROGIN) in Nice, France.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

1st Nonphysician Elected National President Of American Cancer Society
http://www.medicalnewstoday.com/articles/130300.php
Elizabeth T. H. (Terry) Fontham, MPH, DrPH, Dean of the LSU Health Sciences Center New Orleans School of Public Health, became the first non-physician elected national President of the American Cancer Society when she was inducted at a special ceremony during the Society's National Assembly Meeting on November 20, 2008 in New York City.

For Lung Cancer Iressa Proves Just As Effective As Chemotherapy
http://www.medicalnewstoday.com/articles/130297.php
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Holmium Laser Enucleation Of The Prostate-Outcomes Independent Of Prostate Size?
http://www.medicalnewstoday.com/articles/130420.php
UroToday.com - Holmium laser enucleation of the prostate (HoLEP) is emerging as the procedure of choice for men with BPH. This paper highlights the universal appeal of HoLEP for treating prostates of all sizes with excellent functional long-term outcomes and few complications.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Saturday, November 22, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Does Hormone Treatment Predispose Patients To Breast Cancer?
http://www.medicalnewstoday.com/articles/130407.php
Breast cancer, the leading cause of death among women in France, is the most commonly occurring cancer in women. Sporadic breast cancer, which is non-hereditary, turns out to be the most widespread, representing 85 to 90% of all cases, but remains the least well-known.

----------------------------------------------
** CANCER / ONCOLOGY News **

Mechanisms Of Cardiovascular Disease And Cancer Give Clues To New Therapies
http://www.medicalnewstoday.com/articles/130408.php
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level.

Texas Invests Record $3.5 Million In Startup Cofounded By UT's Mauro Ferrari For Cancer Technology
http://www.medicalnewstoday.com/articles/130258.php
NanoMedical Systems Inc., (NMS), an Austin-based startup cofounded by Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston (UTHSC-Houston), to improve the effectiveness of anti-cancer agents and other medications, has received a record $3.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Friday, November 21, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Type Of Breast Reconstruction Impacts Radiation Therapy Outcomes
http://www.medicalnewstoday.com/articles/130275.php
For breast cancer patients who underwent a mastectomy who undergo radiation therapy after immediate breast reconstruction, autologous tissue reconstruction provides fewer long-term complications and better cosmetic results than tissue expander and implant reconstruction, according to a study in the November issue of the<i> International Journal of Radiation Oncology*Biology*Physics</i>, the official journal of the American Society for Therapeutic Radiology and Oncology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Man Says His Dog Detected His Skin Cancer
http://www.medicalnewstoday.com/articles/130393.php
A man from Banbury near Oxford, England, said his dog sniffed out his skin cancer, reminiscent of reports of trials that have shown dogs can detect cancer, in some cases even when screening tests can't.

Scientists Honored For Contributions To Cancer Fight
http://www.medicalnewstoday.com/articles/130371.php
The American Cancer Society - the nation's leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its highest honor, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer.

Tumors Fuelled By Lactic Acid
http://www.medicalnewstoday.com/articles/130327.php
A team of researchers at Duke University Medical Center and the Université catholique de Louvain (UCL) has found that lactic acid is an important energy source for tumor cells. In further experiments, they discovered a new way to destroy the most hard-to-kill, dangerous tumor cells by preventing them from delivering lactic acid.

Tumor Formation May Be Spurred By The Misreading Of Damaged DNA
http://www.medicalnewstoday.com/articles/130325.php
The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses. Most of the time, our cells can repair the damage before it gets copied into a permanent mutation that could lead to cancer.

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients With Non-Small-Cell Lung Cancer (Interest Study)
http://www.medicalnewstoday.com/articles/130288.php
Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of <i>The Lancet</i>, thus establishes gefitinib as a valid treatment option for people with this condition.

Pediatric Cancer : Alteration Of A Gene Causes Neuroblastoma
http://www.medicalnewstoday.com/articles/130248.php
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children neuroblastoma.

Ortho Biotech Announces NDA Submission For Trabectedin For The Treatment Of Relapsed Ovarian Cancer
http://www.medicalnewstoday.com/articles/130233.php
Ortho Biotech Products, L.P. announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection)for the treatment of women with relapsed ovarian cancer (ROC).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

'Urgent Need' For HPV Vaccine In Developing World, Opinion Piece Says
http://www.medicalnewstoday.com/articles/130338.php
<BR>While officials in the United Kingdom and the U.S. are "dithering and doubting" over issues related to <A href="http://www.gsk.com/" target=_new>GlaxoSmithKline</A> and <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Painless, Non-Invasive And Inexpensive Test For Colon Cancer
http://www.medicalnewstoday.com/articles/130303.php
People are often reluctant to undergo a routine but painful colonoscopy - but the consequences can be fatal. According to the American Cancer Society, colon cancer is the third most common cancer found in American men and women and kills about 50,000 Americans every year.

----------------------------------------------
** LUNG CANCER News **

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients With Non-Small-Cell Lung Cancer (Interest Study)
http://www.medicalnewstoday.com/articles/130288.php
Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of <i>The Lancet</i>, thus establishes gefitinib as a valid treatment option for people with this condition.

Amgen, Takeda And Millennium Provide Update On Phase 3 Trial Of Motesanib In Patients With Non Small Cell Lung Cancer
http://www.medicalnewstoday.com/articles/130250.php
Amgen (Nasdaq: AMGN) and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4052), announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Thursday, November 20, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
http://www.medicalnewstoday.com/articles/130227.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment.

Breast Cancer Drug Raises Blood Clot Risk, Should Have 'Black Box' Warning, JAMA Study Says
http://www.medicalnewstoday.com/articles/130130.php
<BR><A href="http://www.gene.com/gene/index.jsp?q=genentech&amp;rls=com.microsoft:*&amp;ie=UTF-8&amp;oe=UTF-8&amp;startIndex=&amp;startPage=1" target=_new>Genentech</A>'s cancer drug Avastin -- which FDA approved in February for treatment of advanced breast cancer -- increases a patient's risk of developing blood clots in veins, a condition known as venous thromboembolism, or VTE, according to a <A href="http://jama.

Family History Raises Breast Cancer Risk Despite Absence Of BRCA Mutations, Study Finds
http://www.medicalnewstoday.com/articles/130129.php
<BR >Women with a strong family history of breast cancer have a four times greater risk for the disease than women in the general population, even if they do not carry a mutation of the BRCA gene, according to a study presented Monday at the <A href="http://www.

Causes Of Bone Loss In Breast Cancer Survivors Identified By Study
http://www.medicalnewstoday.com/articles/130119.php
Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.But a new study has found that cancer drugs aren't the only culprits.

----------------------------------------------
** CANCER / ONCOLOGY News **

Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
http://www.medicalnewstoday.com/articles/130227.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment.

Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
http://www.medicalnewstoday.com/articles/130226.php
Bovie Medical Corporation (the "Company") (NYSE Alternext US: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received 510(k) clearance from the Food and Drug Administration (FDA) to market its SEER tissue resection device intended for initial use in liver oncology surgery.

Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
http://www.medicalnewstoday.com/articles/130213.php
PharmaMar announced today that Ortho Biotech Products, L.P. has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL&reg; (pegylated liposomal doxorubicin) for the treatment of women with relapsed ovarian cancer (ROC).

Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
http://www.medicalnewstoday.com/articles/130209.php
Gentium S.p.A. (NASDAQ: GENT) announced today interim results from an independent Data Safety Monitoring Board (DSMB) review of the Company's Phase 3 treatment trial of Defibrotide for Severe Veno-Occlusive Disease (VOD).

Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
http://www.medicalnewstoday.com/articles/130208.php
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal <i>Proceedings of the National Academy of Sciences</i>.

Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
http://www.medicalnewstoday.com/articles/130150.php
Physicians in the U.S. are reporting a higher risk for certain types of cancers -- such as liver, head, neck and lung -- in people living with HIV/AIDS, raising concerns that a cancer epidemic is imminent in the population, the <a href="http://www.

Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert
http://www.medicalnewstoday.com/articles/130090.php
New data shows that some sarcoma patients are benefiting from treatment with REOLYSIN, developed from a harmless virus called the reovirus that most people are exposed to at some point in their lives.

Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
http://www.medicalnewstoday.com/articles/130086.php
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.

New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
http://www.medicalnewstoday.com/articles/130072.php
Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. But until now, efforts to follow these specially modified cells after their reintroduction to the body have relied on short-term monitoring techniques that don't give a complete picture of the cells' status.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Mexican Department Of Public Health To Launch Screening For Papillomavirus, Cause Of Cervical Cancer
http://www.medicalnewstoday.com/articles/130083.php
In a campaign to significantly reduce the most common cancer affecting Mexican women, the Mexican Public Health Agency (Secretaria de Salud) announced that it is launching the first phase of a program that will offer free testing for human papillomavirus (HPV), the primary cause of cervical cancer, to all low-income women age 35-65.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Lymphoma Association Launches New Short Film
http://www.medicalnewstoday.com/articles/130121.php
The Lymphoma Association is delighted to launch their latest short film which shows the services they offer to anyone affected by lymphoma - the UK's sixth most common cancer. The charity were selected to have the film made for them for a nominal fee by the Media Trust, an organisation which helps charities raise awareness by providing them with volunteers from the TV, film and video industry who then produce videos for them.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade&trade; In Locally Advanced Pancreatic Cancer
http://www.medicalnewstoday.com/articles/130229.php
GenVec, Inc. (Nasdaq:GNVC) announced today top-line results of an interim analysis from its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFerade&trade; (PACT) in patients with locally advanced pancreatic cancer.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Wednesday, November 19, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Two New Compounds Show Promise For Destroying Breast Cancer Tumors - University Of Central Florida
http://www.medicalnewstoday.com/articles/130051.php
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Associate Professor James Turkson's compounds disrupt the formation and spread of breast cancer tumors in tests on mice.

Breast Cancer Prevention Differences In Postmenopausal Women Following Calorie Restriction And Exercise
http://www.medicalnewstoday.com/articles/129989.php
Scientists at the University of Texas at Austin have identified pathways by which a reduced-calorie diet and exercise can modify a postmenopausal woman's risk of breast cancer.The results, presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, suggest that both caloric restriction and exercise affect pathways leading to mTOR, a molecule involved in integrating energy balance with cell growth.

Black, Less-Educated Women Less Likely To Undergo Breast Reconstruction Surgery After Mastectomy, Study Finds
http://www.medicalnewstoday.com/articles/129969.php
Black women are 47% less likely than other women to undergo breast reconstruction after having a mastectomy, according to a study published in the November issue of <cite>Archives of Surgery</cite>, <a href="http://health.

Survival In Breast Cancer Patients Boosted By Intervention Program
http://www.medicalnewstoday.com/articles/129927.php
A new study provides the best evidence to date that a psychological intervention program designed for breast cancer patients not only improves their health - it actually increases their chance of survival.

ER/PR Negative Tumors Associated With Insurance Status
http://www.medicalnewstoday.com/articles/129905.php
African-American women are at a higher risk for ER/PR negative breast cancer. A new study, to be presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, found that race, socioeconomic characteristics and other tumor characteristics are all important predictors of having ER/PR negative breast cancer.

Teaching Breast Health Early To Reduce Breast Cancer Mortality In D.C.
http://www.medicalnewstoday.com/articles/129901.php
Early breast health education may be the key to lowering breast cancer mortality rates in Washington, D.C., which has the highest rates in the country, according to research presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Community Factors Predict Reconstruction After Mastectomy
http://www.medicalnewstoday.com/articles/129842.php
According to new research published in the November issue of <i>Archivesof Surgery</i>, women who live in wealthier communities withlower population densities and a larger proportion of college-educatedindividuals are more likely to have immediate breast reconstructionafter mastectomy.

----------------------------------------------
** CANCER / ONCOLOGY News **

PharmaMar Receives "Supporting A Cure In Our Time" Sarcoma Foundation Of America Award For Commitment With Research In Soft Tissue Sarcoma
http://www.medicalnewstoday.com/articles/130059.php
PharmaMar has received the Award <i>"Supporting A Cure In Our Time"</i> from the Sarcoma Foundation of America (SFA) for its "support in the search for an effective cure for soft tissue sarcomas," goal of the foundation, during the congress of the Connective Tissue Oncology Society (CTOS) held in London from 13-15 November.

ZIOPHARM Oncology Presents Positive Data From Studies Of Palifosfamide
http://www.medicalnewstoday.com/articles/130057.php
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society (CTOS) meeting held in London, UK, November 13 to 15.

Metastatic Melanoma - Provectus Adds 6th Center To Phase 2 Clinical Trial Of PV-10
http://www.medicalnewstoday.com/articles/130055.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a sixth major center located at the California Pacific Medical Center, in San Francisco, CA.

Two New Compounds Show Promise For Destroying Breast Cancer Tumors - University Of Central Florida
http://www.medicalnewstoday.com/articles/130051.php
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Associate Professor James Turkson's compounds disrupt the formation and spread of breast cancer tumors in tests on mice.

Cancer Drug Avastin Raised Risk Of Blood Clots, Study
http://www.medicalnewstoday.com/articles/130048.php
A new analysis of randomized controlled trials of the widely used new generation cancer drug bevacizumab (marketed by Roche and Genentech as Avastin) found it was linked to an increased risk of deep vein blood clots or venous thromboembolism in the legs or lungs compared with treatments that did not use it.

JDRF Funded Research Shows Promise For Prevention, Reversal Of Type 1 Diabetes
http://www.medicalnewstoday.com/articles/130019.php
Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. The JDRF-funded study, published in <i>The Proceedings of the National Academy of Sciences</i>, was led by Jeffrey Bluestone, Ph.

Elderly Cancer Survivors' Ability To Function Improved By Home-Based Interventions
http://www.medicalnewstoday.com/articles/130017.php
Climbing stairs, carrying groceries, taking a shower - these are activities that we take for granted; however, after a cancer diagnosis, many survivors are unable to function as they used to.

Cancer-Killing Cells Tracked Over Prolonged Period Using New Imaging Technique
http://www.medicalnewstoday.com/articles/130009.php
Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. But until now, efforts to follow these specially modified cells after their reintroduction to the body have relied on short-term monitoring techniques that don't give a complete picture of the cells' status.

13 New Tumor-Suppressor Genes In Liver Cancer Identified By Cold Spring Harbor Science Teams
http://www.medicalnewstoday.com/articles/129987.php
Over the years, hunting for cancer-related genes and understanding how they work has been an important, although time-consuming, exercise. At Cold Spring Harbor Laboratory (CSHL), five different research groups have now combined their expertise to speed up the rate of discovering cancer-related genes and validating their function in living animals.

Australia/New Zealand Join Forces On New Treatment Guidelines For Melanoma
http://www.medicalnewstoday.com/articles/129985.php
In a cross-Tasman first, Australia and New Zealand have collaborated with a joint approach to the development of treatment guidelines for cancer, to be launched today (19/11) at the Clinical Oncological Society of Australia Annual Scientific Meeting in Sydney.

Patients Use Touchscreen Technology To Record Pain And Distress
http://www.medicalnewstoday.com/articles/129984.php
Cancer patients in Newcastle, NSW, have been taking part in a unique Australian trial to record levels of pain and distress using touchscreen technology. When out-patients see their doctor at Calvary Mater Newcastle, they use touchscreen computers to complete pain and distress "thermometers", as well as a brief psychological assessment.

Cancer Survival Rates Impact Type Of Web Communities Used By Patients
http://www.medicalnewstoday.com/articles/129981.php
Online support communities for high survival rate cancers contain a greater amount of emotional support content than online support communities for cancers with low survival rates, according to a new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

Vitamin Boosts Immunity Against Skin Cancer
http://www.medicalnewstoday.com/articles/129980.php
Nicotinamide (VitB3), a vitamin found in common foods like meats, nuts, grains and cereals, may provide the next advance in skin cancer prevention, according to new research from the University of Sydney.

Elderly Cancer Survivors' Physical Function Improved By Home-Based Diet And Exercise Intervention
http://www.medicalnewstoday.com/articles/129973.php
A home-based program to improve exercise and diet led to significant, clinically meaningful improvement in body weight and physical function among older long-term cancer survivors in preliminary findings from the RENEW (Reach-out to ENhancE Wellness) trial, according to Wendy Demark-Wahnefried, Ph.

A Post-code Lottery Still Exists For Cancer Patients With "exceptional Circumstances"
http://www.medicalnewstoday.com/articles/129912.php
A study of patients, at the Christie Hospital, Manchester, has shown that the decision to fund patient care depends more on where the patient lives, than the patient's health circumstances, raising public concern regarding a "postcode lottery" since each decision is made solely by the patients' local Primary Care Trust (PCT).

Individuals With HIV Have Higher Risk Of Non-AIDS Cancers
http://www.medicalnewstoday.com/articles/129895.php
The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Community Factors Predict Reconstruction After Mastectomy
http://www.medicalnewstoday.com/articles/129842.php
According to new research published in the November issue of <i>Archivesof Surgery</i>, women who live in wealthier communities withlower population densities and a larger proportion of college-educatedindividuals are more likely to have immediate breast reconstructionafter mastectomy.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

AACR Cancer Prevention Meeting: Georgetown University Medical Center Research Summaries
http://www.medicalnewstoday.com/articles/129993.php
Researchers from Lombardi Comprehensive Cancer Center/Georgetown University Medical Center are presenting numerous scientific findings at the Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research in Washington, Nov.

Lower Socioeconomic Status Decreases Chances Of Early Detection And Survival Of Colorectal Cancer
http://www.medicalnewstoday.com/articles/129903.php
An abstract presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research shows that lower socioeconomic status reduced the chance of early stage diagnosis and survival of colorectal cancer in Colorado.

----------------------------------------------
** LUNG CANCER News **

Lung Cancer Risk In Smokers May Be Lowered By Broccoli
http://www.medicalnewstoday.com/articles/130012.php
The cancer preventive properties of broccoli and other cruciferous vegetables appear to work specifically in smokers, according to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

High Dose Chemotherapy Significantly Prolongs Survival For Patients With Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/129929.php
Preliminary results from a large, randomized clinical trial for patients ages 16 to 60 with previously untreated acute myeloid leukemia (AML), a cancer of the blood and bone marrow, show that patients who received a high dose of a commercially available chemotherapy drug, daunorubicin, during initial therapy lived longer than patients who received a standard dose of the same drug.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Tuesday, November 18, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Dangerous 'Two-Faced' Protein Crucial To Breast Cancer Spread And Growth Identified By Mayo Researchers
http://www.medicalnewstoday.com/articles/129838.php
Two critical properties of cancer cells are their ability to divide without restraint and to spread away from the primary tumor to establish new tumor sites. Now, researchers from the Mayo Clinic campus in Florida have found a protein they say acts as a deadly master switch, both freeing cancer cells from a tumor while ramping up new growth.

Breast Cancer Common Among Women With Family History But Without BRCA1 Or BRCA2
http://www.medicalnewstoday.com/articles/129801.php
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.

Latinas More Likely To Regret Breast Cancer Treatment Decisions, USA
http://www.medicalnewstoday.com/articles/129782.php
Latina women who prefer speaking Spanish are more likely than other ethnic groups to express regret or dissatisfaction with their breast cancer treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

Psychological Interventions Associated With Breast Cancer Survival
http://www.medicalnewstoday.com/articles/129778.php
A new study finds that breast cancer patients who participate in intervention sessions focusing on improving mood, coping effectively, and altering health behaviors live longer than patients who do not receive such psychological support.

Studies To Examine Factors Behind Racial Disparities In Breast, Colon Cancers
http://www.medicalnewstoday.com/articles/129775.php
The following summarizes articles about two cancer studies that examine racial disparities.<ul><li class="AdvisoryBullet">Breast cancer: Researchers from the University of North Carolina's <a href="http://cancer.

Sanofi-Aventis Pharma S.A. Withdraws Its Application For An Extension Ofindication For Taxotere And Docetaxel Winthrop (docetaxel)
http://www.medicalnewstoday.com/articles/129727.php
The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis Pharma S.A. of its decision to withdraw its application for an extension of indication for the centrally authorised medicines Taxotere (docetaxel) 20 mg/0.

Researchers Find Clue To Stopping Breast Cancer Metastasis
http://www.medicalnewstoday.com/articles/129711.php
If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction.

Study: Psychological Help Improves Breast Cancer Survival
http://www.medicalnewstoday.com/articles/129683.php
You've heard the saying 'mind over matter.' Now a new study gives that phrase some scientific backing. Researchers have learned that giving breast cancer patients psychological support along with their medical treatment can dramatically improve their odds of beating the disease.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Biomarkers For Brain Tumor Discovered
http://www.medicalnewstoday.com/articles/129914.php
Researchers in the US and The Netherlands have discovered that cancer cells from a deadly type of human brain tumor called glioblastoma release tiny sacs containing proteins that traverse the brain-blood barrier and contain genetic material that could be used as biomarkers in new diagnostic tools and perhaps as new targets for treatments too.

Thallion Initiates Enrollment In Phase II Metastatic Melanoma Trial
http://www.medicalnewstoday.com/articles/129890.php
Thallion Pharmaceuticals Inc. (TSX:TLN) today announced that the first patient has been enrolled in its Phase II trial evaluating TLN-232 as a treatment for metastatic melanoma in patients who have failed one prior therapy.

In Vivo Model For Human Brain Cancer (Human Glioblastoma GBM) For Drug Discovery Applications Introduced By Celprogen
http://www.medicalnewstoday.com/articles/129880.php
Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated an in vivo model system for testing efficacy of cancer drugs and also novel drug candidates for Human Glioblastoma.

Scientists Find A Trigger To Aggressive Bowel Cancer
http://www.medicalnewstoday.com/articles/129867.php
Cancer Research UK scientists have shown how bowel cancer can become aggressive, according to research published in <i>Nature Genetics*</i>. The researchers, based in the Cardiff School of Biosciences, Cardiff University and at Cancer Research UK's Beatson Institute in Glasgow found that a tumour suppressor protein called Pten is critical in stopping tumours from growing in mice.

Type 1 Diabetes Prevented, Reversed By Two Cancer Drugs, UCSF Study Shows
http://www.medicalnewstoday.com/articles/129861.php
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco.

CAPHOSOL Results In Minimal Oral Mucositis And Pain In Head/neck Cancer Patients
http://www.medicalnewstoday.com/articles/129856.php
New data show that CAPHOSOL&reg; (www.ca<a href="http://www.caphosol.com" target="_blank" rel="nofollow">http://www.caphosol.com</a>phosol.com), an advanced electrolyte solution, results in low rates of oral mucositis and pain in patients with head and neck (HN) cancer who are undergoing chemotherapy and radiation therapy.

Breaking BubR1 Mimics Genetic Shuffle Seen In Cancer Cells
http://www.medicalnewstoday.com/articles/129837.php
A study of how one protein enzyme, BubR1, helps make sure chromosomes are equally distributed during mitosis might explain how the process of cell division goes so awry in cancer, according to researchers from Fox Chase Cancer Center.

Kidney Cancer Risk Could Be Increased By Genes Associated With Fat Metabolism
http://www.medicalnewstoday.com/articles/129804.php
A team of international scientists has identified three genes associated with the body's processing of fats that may increase susceptibility to kidney cancer. The findings were presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Genetic 'signature' In Healthy Liver Cells Predicts Risk Of Liver Cancer Recurrence
http://www.medicalnewstoday.com/articles/129790.php
Researchers have found a gene 'signature' - a specific set of genes - in the healthy, noncancerous cells in the liver of people who have had liver cancer that is associated with better chances of survival and a second gene signature associated with late cancer recurrence, in an international study that has shown for the first time that tissue samples preserved by traditional methods can be used for genetic analysis.

3 Esophageal, Stomach Cancer Subtypes Linked To Smoking; 1 Associated With Alcohol Use
http://www.medicalnewstoday.com/articles/129789.php
Researchers who have been following the health of more than 120,000 residents of the Netherlands for more than two decades have found that smoking is associated with two forms of esophageal cancer as well as a form of stomach cancer, and that drinking alcohol is strongly linked to one form of esophageal cancer.

Latinas More Likely To Regret Breast Cancer Treatment Decisions, USA
http://www.medicalnewstoday.com/articles/129782.php
Latina women who prefer speaking Spanish are more likely than other ethnic groups to express regret or dissatisfaction with their breast cancer treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

Silence On Drug Options "distresses" Cancer Patients
http://www.medicalnewstoday.com/articles/129748.php
Cancer patients want their oncologists to be more up-front about available drug treatments and include them in decision making, even if they cannot afford the treatment, according to new Australian research presented to the Clinical Oncolgoical Society of Australia Annual Scientific Meeting today (18/11) in Sydney.

Exercise And Sleep Reduce Women's Cancer Risk
http://www.medicalnewstoday.com/articles/129735.php
A new US study of nearly 6,000 women found that while regular exercise appeared to reduced their risk of cancer, this benefit was likely to be lost if they did not get enough sleep.The researchers presented their findings at the American Association for Cancer Research's (AACR) Seventh Annual International Conference on Frontiers in Cancer Prevention Research that is taking place in National Harbor, Maryland, this week.

EGFR-Targeting Antibody Licensed To Abbott
http://www.medicalnewstoday.com/articles/129729.php
The international Ludwig Institute for Cancer Research (LICR) has announced that one of its spin-off companies, Life Science Pharmaceuticals, has licensed its lead cancer therapy candidate, antibody 806, to pharmaceutical company Abbott.

Exercise And Rest Reduce Cancer Risk
http://www.medicalnewstoday.com/articles/129709.php
Exercise is good for more than just your waistline. A recent study presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research suggests that regular physical activity can lower a woman's overall risk of cancer but only if she gets a good night's sleep.

Three Esophageal, Stomach Cancer Subtypes Linked To Smoking; One Associated With Alcohol Use
http://www.medicalnewstoday.com/articles/129708.php
Researchers who have been following the health of more than 120,000 residents of the Netherlands for more than two decades have found that smoking is associated with two forms of esophageal cancer as well as a form of stomach cancer, and that drinking alcohol is strongly linked to one form of esophageal cancer.

Behavior/Lifestyle Factors Influence Cancer Risk Among The Elderly
http://www.medicalnewstoday.com/articles/129707.php
Behavioral risk factors have a significant effect on cancer risk in the U.S. elderly population, according to research presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Brain Tumor Cells Release Tiny Sacs Which Carry Information That May Guide Treatment
http://www.medicalnewstoday.com/articles/129701.php
Microvesicles - tiny membrane-covered sacs - released from glioblastoma cells contain molecules that may provide data that can guide treatment of the deadly brain tumor. In their report in the December 2008 <i>Nature Cell Biology</i>, which is receiving early online release, Massachusetts General Hospital (MGH) researchers describe finding tumor-associated RNA and proteins in membrane microvesicles called exosomes in blood samples from glioblastoma patients.

Barrett's Esophagus May Be Affected By DFMO
http://www.medicalnewstoday.com/articles/129694.php
"While there was a suggestion that DFMO may influence the extent of Barrett's dysplasia, this finding is very preliminary and further study of this agent in a larger number of patients is needed," said Frank A.

Long-Term Vitamin E Or Vitamin C Supplementation Does Not Offer Protectiion From Cancer
http://www.medicalnewstoday.com/articles/129693.php
The Physicians' Health Study II is a large-scale, long-term, randomized clinical trial that included 14,641 physicians who were at least 50 years old at enrollment. These physicians were given 400 IU of vitamin E every other day or its placebo, or 500 mg of vitamin C daily or its placebo.

Blood Exosomes Shown To Contain Tumor Specific Genetic Information For Brain Cancer
http://www.medicalnewstoday.com/articles/129686.php
Tiny vesicles called exosomes released into the bloodstream from aggressive brain tumors contain genetic signatures that may help guide future diagnosis and treatment of this deadly disease. In their report in the December issue of <I>Nature Cell Biology</I> (DOI: 10.

Survey Of Beachgoers' Tanning Habits Should Help Interventions To Prevent Skin Cancer
http://www.medicalnewstoday.com/articles/129660.php
A study published in the November issue of <i>Archives ofDermatology</i> seeks to determine which beachgoers would benefitfrom targeted interventions to reduce skin cancer risk by identifyingsun-protection practices and risk profiles.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Studies To Examine Factors Behind Racial Disparities In Breast, Colon Cancers
http://www.medicalnewstoday.com/articles/129775.php
The following summarizes articles about two cancer studies that examine racial disparities.<ul><li class="AdvisoryBullet">Breast cancer: Researchers from the University of North Carolina's <a href="http://cancer.

Role Of Vitamin D In Cancer Therapy Clarified By Study
http://www.medicalnewstoday.com/articles/129737.php
A colon cancer cell isn't a lost cause. Vitamin D can tame the rogue cell by adjusting everything from its gene expression to its cytoskeleton. In the Nov. 17 issue of the <i>Journal of Cell Biology</i>, Ordóñez-Morán et al.

Calcium May Only Protect Against Colorectal Cancer In Presence Of Magnesium
http://www.medicalnewstoday.com/articles/129695.php
High magnesium intake has been associated with low risk of colorectal cancer. Americans have similar average magnesium intake as East Asian populations. If that were all that were involved, observers might expect both groups to have similar risk for colorectal cancer.

----------------------------------------------
** LUNG CANCER News **

Why Only Some Former Smokers Develop Lung Cancer
http://www.medicalnewstoday.com/articles/129803.php
Canadian researchers are trying to answer why some smokers develop lung cancer while others remain disease free, despite similar lifestyle changes.Results were presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Extending Chemotherapy Improves Control Of Lung Cancer
http://www.medicalnewstoday.com/articles/129752.php
A new Australian study has found that extending the use of chemotherapy in patients with advanced non-small cell lung cancer better controls the disease, as well as providing a modest improvement in survival.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Cold/Flu Breakthrough Remedy Undergoes NCI-Sponsored Trial In Leukemia Patients: Canada
http://www.medicalnewstoday.com/articles/129834.php
Cancer patients - with their weakened immune systems - are particularly vulnerable when the cold and flu season hits. To help, the U.S. National Cancer Institute (NCI) is sponsoring a landmark trial to see whether a unique Canadian cold remedy - COLD-FX - can help.

Researchers Tackle CLL, Diabetes And Trauma-Hemorrhage - Molecular Medicine, A Bi-Monthly Journal
http://www.medicalnewstoday.com/articles/129718.php
Chronic Lymphocytic Leukemia (CLL) is a disease of the B lymphocytes of the immune system. Under normal conditions, B lymphocytes (or B cells) play an important role in battling infection. CLL is a disease manifested by uncontrolled growth of these B lymphocytes.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Genetic Risk Factors May Tailor Prostate Cancer Screening Approaches
http://www.medicalnewstoday.com/articles/129805.php
Men with a family history of prostate cancer and African-American men are particularly susceptible to the disease, with a twofold to sevenfold increased risk. Assessing risk in these populations has been difficult.

Growing Number Of Young Prostate Cancer Patients Need 'sexual Rehabilitation'
http://www.medicalnewstoday.com/articles/129757.php
Prostate cancer is being detected and treated at an earlier age, resulting in more cases of erectile dysfunction in younger men. While for many this is a temporary setback, for some it can take much longer and others will never recover their former capability.

Significantly Lower PSA Levels Discovered In Men Who Take Aspirin
http://www.medicalnewstoday.com/articles/129689.php
The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .